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Progressive nodular histiocytosis is a rare non-Langerhans histiocytosis. It tends to occur in adult with
progressive course that differentiates from other groups of xanthogranuloma. The clinical presentation is
characteristic and disﬁguring of the face is not uncommon. Extracutaneous involvement and metabolic
association were reported in a few cases. Treatment is unsatisfactory and follow-up is suggested for
possible complication. Herein, we reported a typical case of the disease.
Copyright  2011, Taiwanese Dermatological Association.
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Progressive nodular histiocytosis (PNH) is a subgroup of xanthog-
ranuloma and belongs to the class of non-Langerhans cell histio-
cytosis. It was ﬁrst described by Taunton et al1 in 1978. It
predominantly affects the young adult in their 3rde4th decades of
life. The patient usually presents with multiple yellowish-brown,
variable-sized papulonodules involving mainly the head, neck,
trunk, and the limbs.2 The lesions tend to progress without spon-
taneous resolution. It is characterized histologically by diffuse
inﬁltrate of spindle-shaped histiocytes with whorl-like growth
pattern, admixed with xanthomatized histiocytes and Touton giant
cells. Herein, we reported a typical case of the disease.
Case report
A 46-year-old man presented with numerous pedunculated
asymptomatic papulonodules over face, trunk, and the upper limbs.
The lesions varied from 0.3 cm to 2 cm and were ﬁrm in consis-
tency. Telangiectasia on an erythematous to yellowish background
can be easily appreciated. The nodules have developed since 6 years
ago, beginning from face to trunk. He ever received skin biopsy
when the lesions were only several and scattered over the
face. Juvenile xanthogranuloma was told. However, the noduleslogy, Chang Gung Memorial
versity, No. 123, Ta-Pei Road,
. Wu).
iwanese Dermatological Associatioincreased in a progressive fashion without spontaneous regression.
The face gradually showed a leonine feature (Figure 1). His respi-
ratory pattern is smooth and there are no dysphagia, hearing
impairment, or signs of ocular involvement. There is no family
member sharing similar cutaneous presentation. The laboratory
survey disclosed hypertriglyceridemia to as high as 334 mg/dL and
a normal cholesterol level. A skin biopsy taken from the largest
nodule on face revealed diffused dermal inﬁltrate, composed of
spindle cells with variable foamy cytoplasm and multinucleated
giant cells, especially the Touton type (Figure 2). The spindle cells
comprised nearly 90% of the cells and showed a storiform
arrangement. There was no cellular atypia and mitotic activity was
absent. The histiocytes stained positive for CD68 and the spindle
cells were negative for smooth muscle actin and desmin. For the
cosmetic purpose, the patient later underwent surgical excision of
the larger nodules on face.
Discussion
PNH is a rare entity and there were only 15 cases reported in the
literature to date. The typical histology is proliferation of storiform,
spindle-shaped histiocytes, conﬁning to the dermis but it may
involve as deep as the muscle layer. Xanthomatous, vacuolated
histiocytes or multinucleated giant cells may be abundant. The
histiocytes are positive for the macrophage/dendritic cell marker
such as CD68 and negative for S100 and CD1a, suggesting the origin
of non-Langerhans cell. The histological ﬁndings resemble several
xanthogranulomatous diseases, such as juvenile xanthogranuloma,
papular xanthoma, benign cephalic histiocytosis, generalized
eruptive histiocytosis, and xanthoma disseminatum. Chu3 hadn. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 (A) Multiple pedunculated papulonodules mainly over face, showing a leonine feature. (B) Also scattered nodules involve the trunk. (C) Close view of the nodule shows
yellowish appearance with telangiectasia.
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However, the differential diagnosis is still possible on clinical
ground. Juvenile xanthogranuloma usually onsets before the age of 6
years and mostly shows a spontaneous resolution. Although severalFigure 2 (A)Whorls of spindle-shaped histiocytes admixed with foamy histioctyes and multi
magniﬁcation, 40]. (B) Touton (arrow) and foreign body (arrow head) giant cells can be e
histiocytes (original magniﬁcation, 200).cases of xanthogranulomawere reported to occur during adulthood,
the lesion was usually solitary.4 Benign cephalic histiocytosis and
generalized eruptive histiocytosis are usually self-limited as well,
whereas xanthoma disseminatum has a predilection for the ﬂexuralnucleated giant cells inﬁltrate the entire dermis [hematoxylin and eosin (H&E); original
asily appreciated (H&E; original magniﬁcation, 200). (C) CD68 stains positive for the
F.-C. Chuang et al. / Dermatologica Sinica 29 (2011) 98e100100area with frequent visceral organ involvement.5 The progressive
course and typical pedunculated nodules characterize the PNH.
However, early diagnosis may be difﬁcult when the lesion number is
few and therefore long-term follow up is necessary for the sus-
pected cases. Our patient with protracted clinical course and char-
acteristic histological feature is a typical case of PNH.
PNH is regarded as solely a cutaneous disease without tendency
of extracutaneous involvement. Systemic survey is required only
when symptoms are present. However, Glavin et al5 reported a case
with a 7-year history of the progressive skin nodularities showing
biopsy-proved extensive laryngeal and pharyngeal involvement
that cause dyspnea and dysphagia. Another case report suggests
the hypothalamic involvement with precocious puberty and
growth failure.6 Gonzalez Ruíz et al7 also imply a possible corre-
lation between chronic myeloid leukemia and long-lasting PNH.
The association between lipid metabolism and PNH is obscure.
Although most of the patients with PNH are normolipemic like
those with juvenile xanthogranuloma, coexisting lipid dysfunction
was reported. Hypercholesterolemia was noted in a 34-year-old
woman with PNH for 7 years.5 Gonzalez Ruíz et al7 demonstrated
another patient with PNH for 26 years showing hypothyroidism
and hypocholesterolemia.7 Our patient presented with hyper-
triglyceridemia and a normal serum cholesterol level. Whether
dyslipidemia is a collision phenomenon or does it play a role in
developing PNH requires further evidence.Treatment of PNH is usually unsatisfactory. Surgical excision
provides temporary relief, but local recurrence is very likely.
Systemic corticosteroid, cyclophosphamide, radiotherapy, or
chemotherapy, such as vincristine, tends to be ineffective.8,9
However, long-term follow-up is still necessary for early detec-
tion to avoid possible complication.
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